This inventor holds 4 USPTO granted patents. Top assignees: Agence Nationale De Valorisation De La Recherche (Anvar), Agence Nationale De Valorisation De La Recherche. Active years: 1977-1990.
Company Filing History:
3 out of 338 
1 out of 46 Years Active: 1977-1990
Title: Eric Selegny: Innovator in Protein Immobilization
Introduction
Eric Selegny is a notable inventor based in Rouen, France. He has made significant contributions to the field of protein science, particularly in the area of protein immobilization. With a total of 4 patents to his name, Selegny's work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
One of Eric Selegny's latest patents focuses on the immobilization of active protein by cross-linking it to inactive protein. This innovative process involves reacting a solution of an active protein substance with an inactive protein substance using a cross-linking agent. The reaction can occur in the presence of an inert carrier under specific cross-linking conditions. The resulting articles can take various forms, including solutions, suspensions, films, membranes, fabrics, porous materials, or masses such as granules, pills, or tablets. The active protein substance can comprise up to about 20 percent by weight, while the cross-linking agent can range from 0.5 to 8 percent by weight based on the total treated mixture.
Career Highlights
Throughout his career, Eric Selegny has worked with prominent organizations, including the Agence Nationale De Valorisation De La Recherche (ANVAR). His experience in these institutions has allowed him to develop and refine his innovative approaches to protein immobilization.
Collaborations
Eric has collaborated with notable individuals in his field, including Georges Broun and Daniel Thomas. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Eric Selegny's contributions to the field of protein science through his innovative patents demonstrate his expertise and commitment to advancing biotechnology. His work continues to influence various applications, showcasing the importance of innovation in scientific research.